期刊论文详细信息
Should Newer Oral Anticoagulants Be Used as First-Line Agents to Prevent Thromboembolism in Patients With Atrial Fibrillation and Risk Factors for Stroke or Thromboembolism? Newer Oral Anticoagulants Should Be Used as First-Line Agents to Prevent Thromboembolism in Patients With Atrial Fibrillation and Risk Factors for Stroke or Thromboembolism | |
Article | |
关键词: XA INHIBITOR EDOXABAN; ANTITHROMBOTIC THERAPY; COST-EFFECTIVENESS; WARFARIN; DABIGATRAN; PHARMACODYNAMICS; PHARMACOKINETICS; TOLERABILITY; CLOPIDOGREL; ASPIRIN; | |
DOI : 10.1161/CIRCULATIONAHA.111.031146 | |
来源: SCIE |
【 授权许可】
Free